Serum neuron-specific enolase as a biomarker in diagnosing diabetic peripheral neuropathy: A cross-sectional study

Serum neuron-specific enolase as a biomarker in diagnosing diabetic peripheral neuropathy: A cross-sectional study

Background: Diabetic peripheral neuropathy remains asymptomatic until the late stages. Hence, a need exists for a reliable and sensitive biomarker for the early diagnosis of diabetic peripheral neuropathy. Aims and Objectives: This study aimed to evaluate serum neuron-specific enolase (NSE) relia...

Full description

Bibliographic Details
Main Authors:	Sangeetha Kandasamy, Babu Krishnan, Shivkumar Gopalakrishnan, Harissh Ganesan
Format:	Article
Language:	English
Published:	Manipal College of Medical Sciences, Pokhara 2022-12-01
Series:	Asian Journal of Medical Sciences
Subjects:	biomarkers; diabetic neuropathy; neuron-specific enolase; peripheral nervous system diseases; type 2 diabetes mellitus
Online Access:	https://www.nepjol.info/index.php/AJMS/article/view/46183

Similar Items

Potential predictive biomarker for diabetic peripheral neuropathy: serum neuron-specific enolase
by: Majeed Islam Fareed, et al.
Published: (2023-12-01)

Diagnostic Value of S100B and Neuron-specific Enolase in Distinguishing Acute Central and Peripheral Vertigo
by: Babak Masoumi, et al.
Published: (2022-12-01)

High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy
by: Yu ZW, et al.
Published: (2020-04-01)

The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey
by: Suayip Birinci, et al.
Published: (2023-09-01)

Application of toluidine blue stain and neuron specific enolase immunohistochemical stain in the diagnosis of hirschsprung disease
by: Tasmia Islam, et al.
Published: (2023-01-01)

Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres
by: Jamie Burgess, et al.
Published: (2021-01-01)

Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management
by: Preston FG, et al.
Published: (2023-06-01)

Serum Neuron-specific Enolase and S100 Calcium-binding Protein B in Pediatric Diabetic Ketoacidosis
by: Hatem Hamed Elshorbagy, et al.
Published: (2019-12-01)

Serum neuron-specific enolase as a marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy
by: Marek Iłżecki, et al.
Published: (2016-01-01)

Neuron-specific enolase during the therapy in patients with alcohol use disorder and mood disorders
by: L. Levchuk, et al.
Published: (2021-04-01)

Gender differences in Diabetic Peripheral Neuropathy
by: Mona Abosrea, et al.
Published: (2020-01-01)

In vivo efficacy of turmeric (Curcuma longa L.) in the treatment of peripheral neuropathy: A systematic review of animal models
by: RAFAEL S. SILVEIRA, et al.
Published: (2023-10-01)

Kadar Neuron-Specific Enolase Serum dan Derajat Ensefalopati Hipoksik Iskemik pada Asfiksia Neonatorum
by: Agus Wijata, et al.
Published: (2016-11-01)

A study on prevalence of diabetic peripheral neuropathy in diabetic patients attending a rural health and training centre
by: K Karthiksaravanan, et al.
Published: (2024-01-01)

Diabetes-induced peripheral neuropathy: Is prescribing physical exercise the answer?
by: Saghir Akhtar
Published: (2024-01-01)

Role of neuron specific enolase, carbohydrate antigen 125, and carbohydrate antigen 199 in monitoring the pulmonary fibrosis progression of pneumoconiosis
by: CHEN Yuquan
Published: (2023-12-01)

Neuron-specific enolase in hypertension patients with acute ischemic stroke and its value forecasting long-term functional outcomes
by: Lingfei Gao, et al.
Published: (2023-05-01)

Comparison of Neuron-specific Enolase (NSE) Serum Level in Patients with Medullary Thyroid Carcinoma and Healthy individuals: Case-Control Study
by: Roghayeh Abbasalipourkabir, et al.
Published: (2022-01-01)

Application of High-Resolution Ultrasound on Diagnosing Diabetic Peripheral Neuropathy
by: Huang H, et al.
Published: (2021-01-01)

MoS<sub>2</sub>@Au as Label for Sensitive Sandwich-Type Immunoassay of Neuron-Specific Enolase
by: Yingying Wang, et al.
Published: (2023-06-01)

Heart rate‐corrected QT interval: A novel diagnostic biomarker for diabetic peripheral neuropathy
by: Ai‐jun Jiang, et al.
Published: (2022-05-01)

Changes in the central nervous system in diabetic neuropathy
by: Yarui Zang, et al.
Published: (2023-08-01)

Diabetic peripheral neuropathy - advances in diagnosis and treatment
by: Paula Bigos, et al.
Published: (2023-07-01)

Expression of Neuron-Specific Enolase and Other Neuroendocrine Markers is Correlated with Prognosis and Response to Therapy in Non-Hodgkin Lymphoma
by: Somshankar Chowdhury, et al.
Published: (2022-12-01)

Role of high-resolution ultrasonography in the evaluation of the tibial and median nerves in diabetic peripheral neuropathy
by: Ranjan Tanu, et al.
Published: (2022-10-01)

Peripheral Nerve Block in Patients with Diabetic Peripheral Neuropathy
by: WANG Jia
Published: (2022-11-01)

Electrodiagnostics or Ultrasound for Diagnosing Diabetic Peripheral Neuropathy [Letter]
by: Hernandez Fustes OJ, et al.
Published: (2021-02-01)

Neuron-Specific Enolase (NSE) as a Biomarker for Autistic Spectrum Disease (ASD)
by: Felician Stancioiu, et al.
Published: (2023-08-01)

The Relationship Between Neuron-Specific Enolase and Clinical Outcomes in Patients Undergoing Mechanical Thrombectomy
by: Peng Q, et al.
Published: (2023-04-01)

Association between Neuron-Specific Enolase, Memory Function, and Postoperative Delirium after Transfemoral Aortic Valve Replacement
by: Jonathan Nübel, et al.
Published: (2023-10-01)

Ultrasound features of diabetic peripheral neuropathy
by: Paloma E. Lopez-Delgadillo, et al.
Published: (2023-07-01)

LEVELS OF NEUROSPECIFIC ENOLASE AND ENOLASE-SPECIFIC AUTOANTIBODIES IN BLOOD SERUM OF THE PATIENTS WITH AUTOIMMUNE THYROPATIES
by: N. N. Tsybikov, et al.
Published: (2014-07-01)

EVALUATION OF BRAIN-BLOOD BARRIER PERMEABILITY FOR NEURON-SPECIFIC ENOLASE DURING PERINATAL HYPOXIC-ISCHEMIC LESION OF THE CNS
by: D. V. Blinov
Published: (2016-06-01)

Non-Pharmacological Balance Therapy on Diabetic Peripheral Neuropathy Patients with Balance Disorders
by: Jeremy Nicolas Sibarani, et al.
Published: (2022-02-01)

Comparing the dynamics of biomarkers of neuron-specific enolase and S-100 protein in neonates with hypoxic-ischemic encephalopathy, depending on the start of therapeutic hypothermia (0–6 h vs. 6–24 h after delivery)
by: D.M. Surkov
Published: (2019-03-01)

Correlation of nerve damage and peripheral neuropathy incidence using the MNSI and MDNS instrument approaches
by: Indah Nur Imamah, et al.
Published: (2024-01-01)

Rehabilitation Interventions for Gait Problems in Patients With Diabetic Peripheral Neuropathy: A Scoping Review
by: Charles Philip Gabel, et al.
Published: (2020-10-01)

Why too soon? Predictors of time to diabetic peripheral neuropathy among newly diagnosed diabetes mellitus patients: a multicenter follow-up study at health-care setting of Ethiopia
by: Gebiso Roba Debele, et al.
Published: (2023-10-01)

Screening for diabetic peripheral neuropathy in resource-limited settings
by: Ken Munene Nkonge, et al.
Published: (2023-03-01)

Role of serum neuron-specific enolase levels in the early diagnosis and prognosis of sepsis-associated encephalopathy: a systematic review and meta-analysis
by: MengQin Pei, et al.
Published: (2024-02-01)